In Vivo looks at how gene therapies have gone from being just implausible science fiction premises, to becoming clinical realities taking an ever-larger portion of pharma R&D attention. This article covers how gene therapies work, where the field has been and where it’s going.
Author: Pharma Intelligence
Published: 19 September 2019
Number of pages:11
Gene therapy is clearly taking medical science to the next level. See how it has taken the leap from treatment to cure and become one of the most exciting technologies in medicine. In Vivo looks at the history of gene therapy from mere fiction to actual cures reaching the market in enough numbers to drive large investment and deal making. See a full list of early triumphs by product, disease, country and originator and other key details, and learn how gene therapies work at the genome level either inside the body or outside before cells are reintroduced to the patient.
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is Suite 1, 3rd Floor, 11 - 12 St. James's Square, London, England, SW1Y 4LB. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.